Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CYTOPLAST RESORB, MODELS R-250, RP-250, RU-250, RPS-250, RPL-250

K-Number: K993610 · 2000-03-02

ApplicantOsteogenics Biomedical, Inc.
Decision Date2000-03-02
Product CodeLYC
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

CYTOPLAST RESORB, MODELS R-250, RP-250, RU-250, RPS-250, RPL-250 is the device name listed in this FDA 510(k) record. The listed applicant is Osteogenics Biomedical, Inc.. It received FDA 510(k) clearance on 2000-03-02 under 510(k) number K993610. The device is classified under product code LYC. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CYTOPLAST RESORB, MODELS R-250, RP-250, RU-250, RPS-250, RPL-250?

CYTOPLAST RESORB, MODELS R-250, RP-250, RU-250, RPS-250, RPL-250 is a medical device that received FDA 510(k) clearance on 2000-03-02. The listed applicant is Osteogenics Biomedical, Inc.. The 510(k) number is K993610.

When did CYTOPLAST RESORB, MODELS R-250, RP-250, RU-250, RPS-250, RPL-250 receive FDA 510(k) clearance?

CYTOPLAST RESORB, MODELS R-250, RP-250, RU-250, RPS-250, RPL-250 received FDA 510(k) clearance on 2000-03-02, under 510(k) number K993610.

Who is the listed applicant for CYTOPLAST RESORB, MODELS R-250, RP-250, RU-250, RPS-250, RPL-250?

The FDA 510(k) record lists Osteogenics Biomedical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CYTOPLAST RESORB, MODELS R-250, RP-250, RU-250, RPS-250, RPL-250?

The FDA product code for CYTOPLAST RESORB, MODELS R-250, RP-250, RU-250, RPS-250, RPL-250 is LYC.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Osteogenics Biomedical, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K201187Cytoplast Titanium-Reinforced PTFE MembranesK171774RPM Reinforced PTFE MeshK093719PRO-FIX PRECISION FIXATION SYSTEM MODEL PFM#, PFB#, PFT#K072076CYTOPLAST PTFE SUTUREK013764IMMIX BONE GRAFT EXTENDERK003028CYTOPLAST SUTURE; CS-0318, CS-0416, CS-0418, CS-0513, CS-0513PC, CS-0516HC

View all 8 devices →

Related Devices (Code: LYC)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253317Cytrans™ ElashieldGC America, Inc.K253883Bonalive MaxillofacialBonalive , Ltd.K251818BONTREE PLUSHudens Bio Co., Ltd.K244006FG Bone Graft MFull Golden Biotech Co., Ltd.K243745FG Bone Graft BFull Golden Biotech CorporationK241186Synthetic Bone Graft ParticulateShenzhen Dazhou Medical Technology Co., Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑